Individualised schedule optimisation improves rates and severity of anaemia in patients (pts) treated with lunresertib (lunre), a PKMYT1 inhibitor, and camonsertib (cam), an ATR inhibitor, in the phase I MYTHIC study (NCT0485565) Meeting Abstract
| Authors: | Højgaard, M.; Yap, T. A.; Lee, E. K.; Weiss, M. C.; Lheureux, S.; Simpkins, F.; LoRusso, P.; Carneiro, B. A.; Moy, R. H.; Aguado-Fraile, E.; Sethuraman, S.; Soria-Bretones, I.; Liu, Y.; Sun, X.; Hawkey, N.; Basciano, P.; Unger, T. J.; Bacqué, E. S.; Schram, A. |
| Abstract Title: | Individualised schedule optimisation improves rates and severity of anaemia in patients (pts) treated with lunresertib (lunre), a PKMYT1 inhibitor, and camonsertib (cam), an ATR inhibitor, in the phase I MYTHIC study (NCT0485565) |
| Meeting Title: | 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 211 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Oct 23-25 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S23 |
| End Page: | S24 |
| Language: | English |
| ACCESSION: | WOS:001345547300056 |
| DOI: | 10.1016/j.ejca.2024.114584 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 57 (PB045) -- Article number: 114584 -- Source: Wos |
